All Articles

Dogtopia is equipping dogs with activity monitors in all its daycares, giving owners unprecedented insight into their pet's health and well-being.

Teal Health's FDA-authorized Teal Wand is now available in all 50 states, aiming to revolutionize preventive care for millions of overdue women.

Omaha-based Core Bank partners with Kobalt Labs, using AI to slash risk review times from days to minutes and safely accelerate its embedded banking strategy.

A Boston biotech, armed with $62M and a new name, unveils a plan to build a universal model of the cell, aiming to predict and control its behavior.

A $7M auction saw a Purdey gun fetch $209K, revealing a red-hot market where history, craftsmanship, and investment potential drive record prices.

Global design firm Populous is evolving, adding real estate strategy to its services to create entire entertainment ecosystems, not just stadiums.

Backed by Frazier Healthcare Partners, the new CareTria aims to slash patient wait times for medication with a powerful, end-to-end technology platform.

Blockchain firm BTCS reports 290% revenue growth, pioneering a new model that blends DeFi with public markets to build an Ethereum powerhouse.

Wearable Devices and Rokid partner to bring touchless gesture control to smart glasses, promising a future where a flick of a finger runs your world.

CEO Joe Hayek will outline a strategy of M&A and innovation to boost value as the company navigates a complex market. Here’s what to expect.

A major HUD loan sale puts 2,500 occupied homes in the balance, pitting investor profits against the fate of non-borrowing family members.

A new mobile app from Reliance Matrix and AllOne Health uses an AI navigator to provide instant, personalized EAP support, aiming to boost low usage.

New system from Montrose tackles a major methane source, promising greater accuracy, technician safety, and faster action on climate goals.

The digital-native waterproof shoe brand Vessi opens its first U.S. store, blending online savvy with a physical footprint and community support.

As Harmony Biosciences presents at JPM, investors will scrutinize its strategy for sustaining growth beyond its star drug and advancing its rare disease pipeline.

A new AI receptionist integrated into HawkSoft aims to end missed calls and manual data entry. But are independent agencies ready to trust the technology?

Pharma giant Lilly and AI biotech BigHat are teaming up to solve a critical flaw in AI drug discovery, aiming to unlock a new generation of therapies.

The deal creates an end-to-end commercialization powerhouse, tackling pharma's toughest payer, reimbursement, and patient affordability challenges.

Instead of selling out, the family-owned natural products giant is making its 1,800 employees owners, securing a legacy of independence and community focus.

With $16.4M in new funding, STRM.BIO is advancing a novel gene therapy platform that uses natural vesicles to target bone marrow, offering new hope for rare diseases.